Hemogenyx Pharmaceuticals

(HEMO)
Sector: Pharmaceuticals & Biotechnology
1.11p
-0.05p -4.31
Last updated: 16:55:00

Share information

Name Hemogenyx Pharmaceuticals
Epic HEMO
Isin GB00BYX3WZ24
Industry Pharmaceuticals & Biotechnology

Key numbers

Latest share price 1.11p Net gearing n/a
Market capitalisation £14.89 Debt ratio n/a
Shares in issue 1,341.82 Debt-to-equity ratio n/a
P/E ratio n/a Assets / equity ratio n/a
Total dividends per share n/a Price to book value n/a
Dividend yield n/a ROCE -64.22
Dividend cover n/a EPS growth n/a
Earning per share -0.5 52-week high / low 1.05p / 3.96p

Dividends

Type Ex-date Pay-date Net-dividend
No dividends declared

Contact details

Company name Hemogenyx Pharmaceuticals
Address 6th Floor, 60 Gracechurch Street, London, United Kingdom, EC3V 0HR
Telephone
Website http://hemogenyx.com/

Directors

Director Position
Dr Vladislav Sandler Ph.D. CEO
Ms Alexis M. Sandler Non-Executive Director
Mr Peter Redmond Non-Executive Director
Sir Marc Feldmann Non-Executive Chairman

Company financials

Assets £ (m) 2022 2021 2020
Reporting date 31/12/22 31/12/21 31/12/20
Intangible asssets and goodwill 0.44 0.44 0.25
Investments and other non-current assets n/a n/a n/a
Total non-current assets 4.5 1.38 0.75
Inventory / work in progress n/a n/a n/a
Trade and other receivables 0.06 0.3 0.1
Cash and equivalents 2.53 6.84 1.81
Other current assets and asset held for resale n/a n/a n/a
Total of all assets 7.09 8.52 2.66
Liabilities £ (m) 2022 2021 2020
Short term liabilities 0.75 0.35 1.78
Long term liabilities 3.1 n/a 0.01
Other liabilites / pension etc n/a n/a n/a
Total of all liabilities 3.85 0.35 1.79
Net assets £ (m) 2022 2021 2020
Net assets 3.24 8.17 0.88
Equity £ (m) 2022 2021 2020
Share capital 9.8 9.8 4.34
Minority interests -0.03 -0.02 -0.02
Retained earnings -17.11 -13.13 -8.04
Share premium account 16.81 16.81 9.99
Total equity 3.24 8.17 0.88
Income £ (m) 2022 2021 2020
Turnover n/a n/a n/a
Operating profit -4 -2.7 -2.15
Pre-tax profit -3.99 -5.11 -2.1